vs
Side-by-side financial comparison of Globavend Holdings Ltd (GVH) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $13.7M, roughly 1.3× Globavend Holdings Ltd). Globavend Holdings Ltd runs the higher net margin — 3.3% vs -3.0%, a 6.3% gap on every dollar of revenue. On growth, Globavend Holdings Ltd posted the faster year-over-year revenue change (63.7% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-1.2M).
Globavend Holdings Ltd is a provider of smart unattended retail solutions, focusing on the design, supply, and operation of intelligent vending machines. It primarily serves markets across Australia, New Zealand, and Southeast Asia, offering end-to-end services including hardware manufacturing, inventory management software, and after-sales support to clients in retail, FMCG, and workplace service segments.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
GVH vs RMTI — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.7M | $18.3M |
| Net Profit | $450.3K | $-554.0K |
| Gross Margin | 10.5% | 21.1% |
| Operating Margin | 5.8% | -2.2% |
| Net Margin | 3.3% | -3.0% |
| Revenue YoY | 63.7% | -25.6% |
| Net Profit YoY | -49.9% | 26.7% |
| EPS (diluted) | $6.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.3M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | — | $16.1M | ||
| Q1 25 | $13.7M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | $8.4M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $450.3K | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $343.0K | ||
| Q1 24 | $898.8K | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | 10.5% | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | 19.8% | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | 5.8% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | 13.8% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -9.3% | ||
| Q1 25 | 3.3% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 10.7% | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $6.01 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | $12.57 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $915.2K | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.7M | $37.0M |
| Total Assets | $6.4M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | $915.2K | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | $2.5M | $6.6M |
| Q4 25 | — | $37.0M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | — | $30.4M | ||
| Q1 25 | $5.7M | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $23.5M | ||
| Q1 24 | $4.4M | $20.6M |
| Q4 25 | — | $57.1M | ||
| Q3 25 | — | $57.5M | ||
| Q2 25 | — | $52.6M | ||
| Q1 25 | $6.4M | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $53.0M | ||
| Q1 24 | $6.0M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-906.3K | $2.3M |
| Free Cash FlowOCF − Capex | $-1.2M | $2.2M |
| FCF MarginFCF / Revenue | -8.8% | 12.0% |
| Capex IntensityCapex / Revenue | 2.2% | 0.5% |
| Cash ConversionOCF / Net Profit | -2.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | $-906.3K | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | $-256.6K | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | $-1.2M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | $-730.0K | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | -8.8% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | -8.7% | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 2.2% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | 5.6% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | -0.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GVH
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
